Advances in the Management of Metastatic Breast Cancer with SABCS Updates
This activity covers the following presentations:Advances in the Management of HR-Positive Metastatic Breast Cancer with SABCS UpdatesAdvances in the Management of HER2-Positive Metastatic Breast Cancer with SABCS Updates
Category
- Breast Cancer
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 ASWB continuing education credit
- 1.00 Participation
Locoregional Management of Breast Cancer with SABCS Updates
This activity covers the following presentations:Updates to Radiation Therapy for DCIS and Invasive Breast Cancer with SABCS UpdatesSurgical Management of Invasive Breast Cancer with SABCS Updates
Category
- Breast Cancer
Format
- Recorded Webcast
Credits
- 1.25 AAPA Category 1 CME credit
- 1.25 ACPE contact hours
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC contact hours
- 1.25 ASWB continuing education credit
- 1.25 Participation
Multigene and Biomarker Testing in Breast Cancer
This activity covers the following presentations:Biomarkers and Gene Panel Testing in Early-Stage Breast CancerNext-Generation Sequencing Testing in the Metastatic Setting
Category
- Breast Cancer
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 ASWB continuing education credit
- 1.00 Participation
Neoadjuvant/Adjuvant Treatment for Breast Cancer with SABCS Updates
This activity covers the following presentations:
Category
- Breast Cancer
Format
- Recorded Webcast
Credits
- 1.25 AAPA Category 1 CME credit
- 1.25 ACPE contact hours
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC contact hours
- 1.25 ASWB continuing education credit
- 1.25 Participation
Recorded Presentation from the NCCN Pharmacy Updates: The Growing Impact of Pharmacogenomics Across the Oncology Landscape
Advances in pharmacogenomics are widespread in the treatment of cancer. The ongoing research in pharmacogenomics has played a vital role in the diagnosis and treatment of oncologic disease states. It is imperative for the interprofessional oncology care team to have a strong understanding of pharmacogenomics and the ability to correctly apply the standard of care for their patients.
Category
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Issues with Sexuality and Sexual Function in Patients with Breast Cancer
Addressing sexual health is an essential step during the treatment of breast cancer. Healthcare providers should discuss with patients the potential changes in sexual function and sexuality related to cancer treatment as well as the measures that are available to overcome these challenges.
Category
- Breast Cancer
- Survivorship
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 ASWB continuing education credit
- 1.00 Participation
Cardiovascular Health After Breast Cancer Treatment
Breast cancer survivors are at increased risk of cardiovascular disease (CVD) and death from cardiovascular complications. Therefore, CVD risk assessment and counseling on CVD risk factor management are recommended for all cancer survivors throughout the survivorship continuum.
Category
- Breast Cancer
- Survivorship
Format
- Recorded Webcast
Credits
- 0.50 AAPA Category 1 CME credit
- 0.50 ACPE contact hours
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC contact hours
- 0.50 Participation
Recorded Presentation from the NCCN Pharmacy Updates: Oncology Stewardship: Best Practices for Pharmacists in Optimizing Patient Safety and Quality of Care
This topic will help fill the gap between current and ideal practice by reviewing examples and best practice recommendations that pharmacists can implement in collaboration with interprofessional team members to improve resource utilization, patient safety, and quality of care.
Category
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Archived Monthly Oncology Tumor Boards: Systemic Therapy for Metastatic Prostate Cancer
Learn about the results of recent trials, updates to NCCN Guideline recommendations, and common supportive care needs, so that you can provide optimal management for patients with metastatic prostate cancer.
Category
- Prostate Cancer
Format
- Recorded Webcast
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
NCCN Guidelines® Insights - Bladder Cancer, Version 3.2024
These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Bladder Cancer, including changes in the fifth edition of the WHO Classification of Tumours: Urinary and Male Genital Tumours and how the NCCN Guidelines aligned with these updates; new and emerging treatment options for bacillus Calmette-Guérin (BCG)–unresponsive NMIBC; and updates to systemic therapy recommendations for advanced or metastatic disease.
Category
- Bladder Cancer
Format
- Monograph/Journal Supplement
Credits
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation